Cargando…

Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment

Cancer is the leading cause of death after cardiovascular disease. Despite significant advances in cancer research over the past few decades, it is almost impossible to cure end-stage cancer patients and bring them to remission. Adverse effects of chemotherapy are mainly caused by the accumulation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahriar, S. M. Shatil, Andrabi, Syed Muntazir, Islam, Farhana, An, Jeong Man, Schindler, Samantha J., Matis, Mitchell P., Lee, Dong Yun, Lee, Yong-kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784306/
https://www.ncbi.nlm.nih.gov/pubmed/36559206
http://dx.doi.org/10.3390/pharmaceutics14122712
_version_ 1784857779105693696
author Shahriar, S. M. Shatil
Andrabi, Syed Muntazir
Islam, Farhana
An, Jeong Man
Schindler, Samantha J.
Matis, Mitchell P.
Lee, Dong Yun
Lee, Yong-kyu
author_facet Shahriar, S. M. Shatil
Andrabi, Syed Muntazir
Islam, Farhana
An, Jeong Man
Schindler, Samantha J.
Matis, Mitchell P.
Lee, Dong Yun
Lee, Yong-kyu
author_sort Shahriar, S. M. Shatil
collection PubMed
description Cancer is the leading cause of death after cardiovascular disease. Despite significant advances in cancer research over the past few decades, it is almost impossible to cure end-stage cancer patients and bring them to remission. Adverse effects of chemotherapy are mainly caused by the accumulation of chemotherapeutic agents in normal tissues, and drug resistance hinders the potential therapeutic effects and curing of this disease. New drug formulations need to be developed to overcome these problems and increase the therapeutic index of chemotherapeutics. As a chemotherapeutic delivery platform, three-dimensional (3D) scaffolds are an up-and-coming option because they can respond to biological factors, modify their properties accordingly, and promote site-specific chemotherapeutic deliveries in a sustainable and controlled release manner. This review paper focuses on the features and applications of the variety of 3D scaffold-based nano-delivery systems that could be used to improve local cancer therapy by selectively delivering chemotherapeutics to the target sites in future.
format Online
Article
Text
id pubmed-9784306
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97843062022-12-24 Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment Shahriar, S. M. Shatil Andrabi, Syed Muntazir Islam, Farhana An, Jeong Man Schindler, Samantha J. Matis, Mitchell P. Lee, Dong Yun Lee, Yong-kyu Pharmaceutics Review Cancer is the leading cause of death after cardiovascular disease. Despite significant advances in cancer research over the past few decades, it is almost impossible to cure end-stage cancer patients and bring them to remission. Adverse effects of chemotherapy are mainly caused by the accumulation of chemotherapeutic agents in normal tissues, and drug resistance hinders the potential therapeutic effects and curing of this disease. New drug formulations need to be developed to overcome these problems and increase the therapeutic index of chemotherapeutics. As a chemotherapeutic delivery platform, three-dimensional (3D) scaffolds are an up-and-coming option because they can respond to biological factors, modify their properties accordingly, and promote site-specific chemotherapeutic deliveries in a sustainable and controlled release manner. This review paper focuses on the features and applications of the variety of 3D scaffold-based nano-delivery systems that could be used to improve local cancer therapy by selectively delivering chemotherapeutics to the target sites in future. MDPI 2022-12-03 /pmc/articles/PMC9784306/ /pubmed/36559206 http://dx.doi.org/10.3390/pharmaceutics14122712 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Shahriar, S. M. Shatil
Andrabi, Syed Muntazir
Islam, Farhana
An, Jeong Man
Schindler, Samantha J.
Matis, Mitchell P.
Lee, Dong Yun
Lee, Yong-kyu
Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment
title Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment
title_full Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment
title_fullStr Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment
title_full_unstemmed Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment
title_short Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment
title_sort next-generation 3d scaffolds for nano-based chemotherapeutics delivery and cancer treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784306/
https://www.ncbi.nlm.nih.gov/pubmed/36559206
http://dx.doi.org/10.3390/pharmaceutics14122712
work_keys_str_mv AT shahriarsmshatil nextgeneration3dscaffoldsfornanobasedchemotherapeuticsdeliveryandcancertreatment
AT andrabisyedmuntazir nextgeneration3dscaffoldsfornanobasedchemotherapeuticsdeliveryandcancertreatment
AT islamfarhana nextgeneration3dscaffoldsfornanobasedchemotherapeuticsdeliveryandcancertreatment
AT anjeongman nextgeneration3dscaffoldsfornanobasedchemotherapeuticsdeliveryandcancertreatment
AT schindlersamanthaj nextgeneration3dscaffoldsfornanobasedchemotherapeuticsdeliveryandcancertreatment
AT matismitchellp nextgeneration3dscaffoldsfornanobasedchemotherapeuticsdeliveryandcancertreatment
AT leedongyun nextgeneration3dscaffoldsfornanobasedchemotherapeuticsdeliveryandcancertreatment
AT leeyongkyu nextgeneration3dscaffoldsfornanobasedchemotherapeuticsdeliveryandcancertreatment